Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.72 |
| ▸ | SRC | P12931 | 3/20 | 0.69 |
| ▸ | NR1H4 | Q96RI1 | 7/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | ARHGEF12 | Q9NZN5 | 1/20 | 0.66 |
| ▸ | JAK2 | O60674 | 1/20 | 0.62 |
| ▸ | ZAP70 | P43403 | 1/20 | 0.62 |
| ▸ | PPARG | P37231 | 1/20 | 0.62 |
| ▸ | ABL1 | P00519 | 2/20 | 0.61 |
| ▸ | SIRT1 | Q96EB6 | 4/20 | 0.60 |
| ▸ | SIRT5 | Q9NXA8 | 4/20 | 0.60 |
| ▸ | SIRT2 | Q8IXJ6 | 3/20 | 0.60 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5453405 | 0.86 | KMT2A (0.68) | EGFRSRCNR1H4MEN1KMT2A | |
| SCHEMBL5453408 | 0.86 | KMT2A (0.68) | EGFRSRCNR1H4MEN1KMT2A | |
| SCHEMBL5444779 | 0.84 | KMT2A (0.65) | EGFRSRCNR1H4MEN1KMT2A | |
| SCHEMBL5448904 | 0.84 | KMT2A (0.65) | EGFRSRCNR1H4MEN1KMT2A | |
| SCHEMBL5448905 | 0.84 | KMT2A (0.65) | EGFRSRCNR1H4MEN1KMT2A | |
| SCHEMBL5444775 | 0.84 | KMT2A (0.65) | EGFRSRCNR1H4MEN1KMT2A | |
| SCHEMBL25138474 | 0.80 | NR1H4 (1.00) | EGFRSRCNR1H4MEN1KMT2A | |
| SCHEMBL15936914 | 0.80 | NR1H4 (1.00) | EGFRSRCNR1H4MEN1KMT2A | |
| SCHEMBL22523873 | 0.79 | SIRT1 (0.74) | NR1H4MEN1KMT2APPARGSIRT1 | |
| SCHEMBL15421780 | 0.77 | PPARG (1.00) | NR1H4MEN1KMT2APPARGSIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9951024-B2 | Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2018-04-24 | — | — | US | disclosed |
| US-20170349553-A1 | SMALL- MOLECULE INHIBITORS TARGETING G-PROTEIN-COUPLED RHO GUANINE NUCLEOTIDE EXCHANGE FACTORS | UNIVERSITY OF CINCINNATI | 2017-12-07 | — | — | US | disclosed |
| US-20160083353-A1 | SMALL-MOLECULE INHIBITORS TARGETING G-PROTEIN-COUPLED RHO GUANINE NUCLEOTIDE EXCHANGE FACTORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-03-24 | — | — | US | disclosed |
| WO-2014120683-A1 | SMALL-MOLECULE INHIBITORS TARGETING G-PROTEIN-COUPLED RHO GUANINE NUCLEOTIDE EXCHANGE FACTORS | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2014-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083353-A1 | SMALL-MOLECULE INHIBITORS TARGETING G-PROTEIN-COUPLED RHO GUANINE NUCLEOTIDE EXCHANGE FACTORS | ARHGEF1, ARHGEF2, ARHGDIB | EGFR 3095/4885SRC 726/4885NR1H4 1982/4885 |
| US-20170349553-A1 | SMALL- MOLECULE INHIBITORS TARGETING G-PROTEIN-COUPLED RHO GUANINE NUCLEOTIDE EXCHANGE FACTORS | ARHGEF1, ARHGEF2, ARHGDIB | EGFR 3095/4885SRC 726/4885NR1H4 1982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.